БЛОГ

Mar 8, 2020

Stanford Doctor to Get $191 Million for Cancer-Fighting Biotech

Posted by in category: biotech/medical

A Stanford University professor and stem cell pioneer whose first job in science paid $25 a month is poised to receive a $191 million windfall from the sale of the immunotherapy biotech firm he co-founded.

Irv Weissman, 80, owns 4.2% of Forty Seven Inc., which Gilead Sciences Inc. agreed to buy for about $4.9 billion, a remarkable amount considering the company’s market value was less than $250 million just five months ago.

Comments are closed.